Search results
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
GuruFocus.com via Yahoo Finance· 4 days agoThe details were released through an 8-K filing. This announcement comes in the wake of a...
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 6 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 2 days agoHere are two top stocks to consider buying now that you can hold for at least a decade. 1. Vertex ...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 13 hours agoCasgevy was developed in a partnership with Vertex Pharmaceuticals, which seems to be valuable for...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 6 days agoThe stock market rally had a quiet session for a second straight day. Nvidia fell slightly for a...
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks· 7 days agoFree Report) reported revenue of $2.69 billion, up 13.3% over the same period last year. The company delivered an EPS surprise of +16.10%, with the consensus EPS estimate being $4.10. While ...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
GuruFocus.com via Yahoo Finance· 4 days agoThis financial stability supports the company's ongoing and future R&D efforts. Strategic Collaborations and Future Directions The company continues to benefit from its strategic collaboration ...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will discuss the 10 stocks whose price targets were recently raised by analysts....
Remembering Quant King Jim Simons
GuruFocus.com via Yahoo Finance· 1 day agoOther notable top stocks that have had a long-term, continuous presence in the equity portfolio include VeriSign Inc. (NASDAQ:VRSN) and Vertex ...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 5 days agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...
